arrow
K

Karel Hejduk

Institute of Health Information and Statistics of the Czech Republic
H指数:19
被引数:857

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring motivations and barriers in prostate cancer screening: lessons from a volunteer-based MRI screening study

探索前列腺癌筛查的动机与障碍:来自一项基于志愿者的MRI筛查研究的启示

2025-11-180
OAAI
ProstaPilot: A Comparative Study of Biparametric Magnetic Resonance Imaging Versus Prostate-specific Antigen as a Screening Test for Prostate Cancer

ProstaPilot:一项关于双参数磁共振成像与前列腺特异性抗原作为前列腺癌筛查试验的比较研究

2025-06-010
PRE
COVID-19's natural course among ambulatory monitored outpatients
2021-05-128
OAAI
Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE

接受抗纤维化治疗的中欧特发性肺纤维化 (IPF) 患者的抗凝剂使用和出血风险: 来自EMPIRE的真实数据

2020-07-3014
OAAI
Long-term overall survival and progression-free survival in idiopathic pulmonary fibrosis treated by pirfenidone or nintedanib or their switch. Real world data from the EMPIRE registry
2019-11-215
PRE
Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from the Czech Republic
2018-11-190
PRE
Comparison of NSCLC patient groups with activated EGFR mutations treated with three different tyrosine-kinase inhibitors (TKI): Real-life data from the Czech Republic
2017-12-060
PRE
Respiratory parameters predict mortality in COPD patients - data from the Czech multicentre research database of severe COPD
2017-12-060
PRE